Streetbeat News

Price Targets

TDY

Needham analyst James Ricchiuti has reaffirmed a Buy rating on Teledyne Technologies (NYSE:TDY) and increased the price target from $455 to $522.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:57 am

XOMA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on XOMA (NASDAQ:XOMA) and maintained a $74 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:54 am

CFG

Citigroup analyst Keith Horowitz has maintained a Neutral rating on Citizens Financial Group (NYSE:CFG) and increased the price target from $30 to $34.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:35 am

DV

Needham analyst Laura Martin has reiterated a Buy rating on DoubleVerify Holdings (NYSE:DV) and maintained a $45 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:31 am

EOG

PXD

SLB

TTE

Wall Street analysts have provided updates on energy stocks, with varying ratings and price targets. TotalEnergies SE (TTE) received mixed reviews, with a price target cut by TD Cowen and Piper Sandler. Schlumberger Limited (SLB) saw positive ratings from Barclays and Societe Generale, with increased price targets. EOG Resources, Inc. (EOG) had a price target cut by Raymond James but maintained a Strong Buy rating, while Wells Fargo downgraded the stock. Pioneer Natural Resources Company (PXD) faced downgrades from Argus Research and Raymond James despite posting better-than-expected earnings.

Portfolio Pulse from Avi Kapoor

December 22, 2023 | 11:29 am

LEGN

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Legend Biotech (NASDAQ:LEGN) and maintained the price target of $87.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:20 am

NKE

Stifel analyst Jim Duffy has maintained a Buy rating on Nike (NYSE:NKE) but has reduced the price target from $135 to $129.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:17 am

BHVN

HC Wainwright & Co. analyst Douglas Tsao has initiated coverage on Biohaven (NYSE:BHVN) with a Buy rating and set a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:12 am

ALPN

HC Wainwright & Co. analyst Joseph Pantginis has reaffirmed a Buy rating on Alpine Immune Sciences (NASDAQ:ALPN) and increased the price target from $17 to $32. This adjustment reflects a more optimistic outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:10 am

GAU

HC Wainwright & Co. analyst Heiko Ihle has reiterated a Buy rating on Galiano Gold (AMEX:GAU) and maintained a price target of $2.2 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:10 am